Physician

Alejandra Rodriguez-Paez, M.D.

According to 2025 Medicare claims, Alejandra Rodriguez-Paez, M.D. (NPI: 1356556013) practices rheumatology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is ILLINOIS BONE AND JOINT INSTITUTE LLC (NPI: 1205922432; TIN: 20-3845479) and primary practice location at 60053-2127.

Rodriguez-Paez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 871 traditional Medicare patients, billed 272,404 HCPCS/CPT codes, and received $3,086,773 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,128 prescription claims across 682 beneficiaries totaling $1,507,316 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 7 records totaling $817. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $156,548 to $3,086,773. Similarly, Part D prescription costs have moved sharply higher in recent years, from $303,853 to $1,507,316. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	414	5,668	$156,548
2016	581	47,263	$884,052
2017	600	67,898	$1,238,517
2018	759	70,665	$1,459,170
2019	824	65,333	$1,404,429
2020	802	163,027	$2,233,490
2021	926	198,783	$2,574,100
2022	954	213,031	$2,519,422
2023	952	235,599	$2,861,398
2024	871	272,404	$3,086,773

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	311	1,685	$303,853
2016	287	1,421	$166,806
2017	309	1,972	$470,309
2018	370	2,362	$442,102
2019	406	2,347	$475,014
2020	466	2,425	$557,473
2021	544	3,417	$953,434
2022	571	3,671	$1,124,810
2023	593	3,768	$1,351,621
2024	682	4,128	$1,507,316

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	702	1,272	$98
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	546	918	$13
80053	Blood test, comprehensive group of blood chemicals	588	981	$10
36415	Insertion of needle into vein for collection of blood sample	640	1,151	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	567	972	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	35	980	$347,284
Rinvoq	Upadacitinib	32	1,020	$240,313
Humira(Cf)	Adalimumab	22	616	$151,681
Xeljanz	Tofacitinib Citrate	19	570	$120,293
Enbrel Sureclick	Etanercept	12	392	$111,745

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$817	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alejandra Rodriguez-Paez, M.D.?

Tedicare shows public-source Medicare data for Alejandra Rodriguez-Paez, M.D. (NPI 1356556013), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alejandra Rodriguez-Paez, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alejandra Rodriguez-Paez, M.D.?

Alejandra Rodriguez-Paez, M.D. is linked to ILLINOIS BONE AND JOINT INSTITUTE LLC (billing NPI 1205922432) in the available physician profile data.

Does Alejandra Rodriguez-Paez, M.D. have Open Payments data?

Alejandra Rodriguez-Paez, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.